Brewin Dolphin Wealth Management LTD Repligen Corp Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Repligen Corp stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 113 shares of RGEN stock, worth $17,712. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113
Previous 113
-0.0%
Holding current value
$17,712
Previous $21,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
511Shares Held
58.9MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.19 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$1.04 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$796 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$300 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$254 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.7B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....